Farringdon Capital, Ltd. Geron Corp Transaction History
Farringdon Capital, Ltd.
- $198 Billion
- Q1 2025
A detailed history of Farringdon Capital, Ltd. transactions in Geron Corp stock. As of the latest transaction made, Farringdon Capital, Ltd. holds 31,652 shares of GERN stock, worth $38,298. This represents 0.03% of its overall portfolio holdings.
Number of Shares
31,652Holding current value
$38,298% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding GERN
# of Institutions
302Shares Held
500MCall Options Held
799KPut Options Held
463K-
Ra Capital Management, L.P. Boston, MA60.4MShares$73.1 Million1.99% of portfolio
-
Black Rock Inc. New York, NY46.6MShares$56.3 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT38.2MShares$46.2 Million2.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA34.1MShares$41.3 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA27.2MShares$32.9 Million11.75% of portfolio
About GERON CORP
- Ticker GERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 377,819,008
- Market Cap $457M
- Description
- Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...